Adicet Bio, Inc.
ACET· Nasdaq
Released Mar 6, 2025, after the close
10-K filed Mar 6, 2025, 65 days after period end · 0000950170-25-034587
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$28.73M | -$29.49M | -$29.87M | -$15.81M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Mar 6, 2025 · 65 d after period end
2.8% from the close of Mar 6, 2025 to the close of Mar 7, 2025, the first after the release.